Gert van der Hoek
In Memoriam - Editor, Senior Moderator
snip from study.
Thorax 2009;64:828; doi:10.1136/thx.2009.126102
Influenza A resistance to oseltamivir
I Ismail
Correspondence to:
Correspondence to Dr I Ismail, CT2, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK; iyad75@hotmail.co.uk
Oseltamivir is a neuraminidase inhibitor used for the treatment and prophylaxis of influenza A infections.
This study investigated the differences in demographics, epidemiology, clinical symptoms, severity of illness and clinical outcomes among patients infected with oseltamivir-resistant or oseltamivir-susceptible influenza A (H1N1) virus in the USA.
Information about viral isolates and their subtypes, particularly H1N1, was collected using data submitted to the Centres for Disease Control and Prevention by US public health laboratories.
Data about illnesses from both groups were collected over the telephone using a standardised questionnaire.
142 out of 1155 cases of influenza A (H1N1) tested were resistant to oseltamivir.
Data were collected from 99 oseltamivir-resistant patients who agreed to participate and 182 oseltamivir-susceptible cases.
Among resistant patients the median age was 19 years; five patients (5%) were hospitalised and four patients (4%) died.
Only the first 150 words of the study could be read.
http://thorax.bmj.com/cgi/content/short/64/9/828?rss=1
Thorax 2009;64:828; doi:10.1136/thx.2009.126102
Influenza A resistance to oseltamivir
I Ismail
Correspondence to:
Correspondence to Dr I Ismail, CT2, University Hospital of South Manchester NHS Foundation Trust, Manchester, UK; iyad75@hotmail.co.uk
Oseltamivir is a neuraminidase inhibitor used for the treatment and prophylaxis of influenza A infections.
This study investigated the differences in demographics, epidemiology, clinical symptoms, severity of illness and clinical outcomes among patients infected with oseltamivir-resistant or oseltamivir-susceptible influenza A (H1N1) virus in the USA.
Information about viral isolates and their subtypes, particularly H1N1, was collected using data submitted to the Centres for Disease Control and Prevention by US public health laboratories.
Data about illnesses from both groups were collected over the telephone using a standardised questionnaire.
142 out of 1155 cases of influenza A (H1N1) tested were resistant to oseltamivir.
Data were collected from 99 oseltamivir-resistant patients who agreed to participate and 182 oseltamivir-susceptible cases.
Among resistant patients the median age was 19 years; five patients (5%) were hospitalised and four patients (4%) died.
Only the first 150 words of the study could be read.
http://thorax.bmj.com/cgi/content/short/64/9/828?rss=1